April 22, 2025
MRD and Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB–IIIA NSCLC
April 22, 2025
Extended Follow-up of Belzutifan Treatment for von Hippel–Lindau Disease–Associated Renal Cell Carcinoma
April 21, 2025
Therapy With a Tyrosine Kinase Inhibitor for EGFR-Variant Lung Adenocarcinoma: Lessons From Chronic Myeloid Leukemia?
Latest Headlines
View MoreApril 23, 2025
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
April 23, 2025
Polygenic Risk Score for Prostate Cancer Screening
April 23, 2025
Is This the End of Cancer Research as We Know It?
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Conference Coverage
Vascular Discovery 2025 Scientific Sessions
2024 ASTRO Annual Meeting
SGO 2025 Annual Meeting on Womens Cancer
Clinical Guidelines
View More
Commentary & Perspectives
View More
FDA & Government News
View More
Business Management
View More
April 10, 2025
American Cancer Society Launches CEO Search
September 18, 2023
Cancer Moonshot Initiative Receives $240 Million Boost
September 11, 2023